Weiqi Wang

State Key Laboratory Of Digestive Health, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100050, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer.

Identification of PLXNC1 as a novel biomarker for consensus molecular subtype 4 in colorectal cancer.

Journal: Genes & diseases

Published: July 11, 2024

Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.

Developing an m5C regulator-mediated RNA methylation modification signature to predict prognosis and immunotherapy efficacy in rectal cancer.

Journal: Frontiers in immunology

Published: September 27, 2022

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.

Characterization of sialylation-related long noncoding RNAs to develop a novel signature for predicting prognosis, immune landscape, and chemotherapy response in colorectal cancer.

Journal: Frontiers in immunology

Published: July 15, 2022

Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.

Comprehensive Analysis of a Cancer-Immunity Cycle-Based Signature for Predicting Prognosis and Immunotherapy Response in Patients With Colorectal Cancer.

Journal: Frontiers in immunology

Published: March 09, 2022

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.

Prognostic Values and Underlying Regulatory Network of Cohesin Subunits in Esophageal Carcinoma.

Journal: Journal of Cancer

Published: September 09, 2021

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Comprehensive bioinformatics analysis identifies LAPTM5 as a potential blood biomarker for hypertensive patients with left ventricular hypertrophy.

Journal: Aging

Published: August 10, 2021

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.

SEMA6B Overexpression Predicts Poor Prognosis and Correlates With the Tumor Immunosuppressive Microenvironment in Colorectal Cancer.

Journal: Frontiers in molecular biosciences

Published: March 29, 2021

A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019.

A bioinformatics analysis on the potential role of ACE2 in cardiac impairment of patients with coronavirus disease 2019.

Journal: Annals of translational medicine

Published: December 14, 2020

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.

Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis.

Journal: Frontiers in oncology

Published: August 27, 2020

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma.

Prognostic significance of mutant-allele tumor heterogeneity in uterine corpus endometrial carcinoma.

Journal: Annals of translational medicine

Published: May 02, 2020

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.

High SEMA4C expression promotes the epithelial-mesenchymal transition and predicts poor prognosis in colorectal carcinoma.

Journal: Aging

Published: March 03, 2020

Showing 1-11 of 11

Last Updated: 09/26/2026